Sep 7, 2026

Featuring perspectives from Prof John Seymour and cases from Dr Daniel Ermann, Dr Shazia Nakhoda and Dr Mahesh Swaminathan, including the following topics:

• Case: A woman in her mid 50s with multiple sclerosis, hypertension, IGHV-unmutated chronic lymphocytic leukemia (CLL) with an SF3B1 mutation and autoimmune...

Sep 6, 2026

Featuring perspectives from Prof John Seymour, including the following topics:

• Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00)
• Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21)
• First-line treatment with sonrotoclax and zanubrutinib...

Sep 2, 2026

Featuring perspectives from Dr William G Wierda, including the following topics:

• Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00)
• Sequencing Road Map (12:39)
• Key Datasets — Pirtobrutinib (21:08)
• Investigator Survey (34:09)
• Chimeric Antigen Receptor T-Cell Therapy (45:08)
• Other...

Aug 26, 2026

Featuring perspectives from Dr Matthew Matasar and Dr Sonali M Smith, including the following topics:

• Introduction: Lymphoma Survivorship (0:00)
• Novel Treatment Approaches for Diffuse Large B-Cell Lymphoma — Dr Matasar (6:49)
• Novel Treatment Approaches for Follicular Lymphoma and Mantle Cell Lymphoma — Dr Smith...

Aug 25, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Novel Treatment Approaches for Non-Hodgkin Lymphoma | Faculty Presentation 2: Novel Treatment Approaches for Follicular Lymphoma and Mantle Cell Lymphoma — Sonali M Smith, MD

CME information and select...